LGALS3 and type 1 diabetes mellitus: In this study, we report that in patients with T1D, an elevated circulating lipopolysaccharide (LPS) level, resulting from increased intestinal permeability, stimulates monocytes/macrophages to secrete excessive Galectin-3, suggesting that Galectin-3 has the potential to serve as a promising biomarker for T1D.